Homepage
Vicore Announces FDA Breakthrough Device Designation for Almee
Vicore Pharma Holding AB have announced FDA Breakthrough Device Designation status for Almee, a 9-week digital cognitive behavioural therapy (CBT), to be used as an adjunct treatment of anxiety symptoms related to PF. Read more
19 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Orchard Therapeutics Receives FDA Approval of Lenmeldy
Orchard Therapeutics, recently acquired by Kyowa Kirin, have announced the U.S. FDA has approved Lenmeldy for the treatment of children with early-onset—metachromatic leukodystrophy. Read more
19 Mar 2024
Fusion Pharmaceuticals to be Acquired by AstraZeneca
Fusion Pharmaceuticals, a clinical-stage oncology company focused on developing next-generation radioconjugates (RCs) as precision medicines, have announced the Company has entered into a definitive agreement to be acquired by AstraZeneca. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Bluebird Bio Secures up to $175 Million Debt Financing
Bluebird Bio has entered into a $175 million five-year, term loan facility with Hercules Capital. The transaction strengthens the Company’s balance sheet as it executes on the commercial launches for its three FDA approved gene therapies. Read more
19 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novartis Invest $256 million in Singapore Biopharmaceutical Manufacturing Facility
Novartis recently announced it broke ground for the $256 million expansion of its biopharmaceutical manufacturing plant in Singapore. Read more
18 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
European Commission Approves Pfizer’s PREVENAR 20
Pfizer Inc have announced that the European Commission (EC) has granted marketing authorisation for the company’s 20-valent pneumococcal conjugate vaccine, marketed in the European Union under the brand name PREVENAR 20. Read more
18 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
AstraZeneca to acquire Amolyt Pharma
AstraZeneca announced that it has entered into a definitive agreement to acquire Amolyt Pharma, a clinical-stage biotechnology company focused on developing novel treatments for rare endocrine diseases. Read more
14 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Global Conglomerates Commit $600 Million to Cervical Cancer Treatments
Governments, donors, multilateral institutions, and partners announced major new policy, programmatic and financial commitments, including nearly $600 million in new funding, to eliminate cervical cancer. Read more
6 Mar 2024
Pharma Manufacturing News + Pharma Finance and Investment News
Novo Nordisk Kidney Trial Finds Ozempic Reduces Risk of Kidney Disease-Related Events
Novo Nordisk have announced the headline results from the kidney outcomes trial FLOW. The announcement follows the decision to stop the trial early due to efficacy, which was announced on 10 October 2023. Read more
5 Mar 2024
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
White Papers
New dosage forms come with new challenges:
A guide to overcoming analysis and quality control issues in R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25
SGD Pharma Successfully Trials Hydrogen Burners at Saint-Quentin-Lamotte Plant
SGD Pharma recently started a two-week trial using 100% hydrogen burners for industrial-scale glass production. Read more
12 Mar 2024
Pharma Manufacturing News + Pharmaceutical Sustainability News
MM Packaging Achieve Triple A Carbon Disclosure Project Score
MM Packaging, secondary packaging specialist to the pharmaceutical sector, announces its achievement of Triple A certification from the Carbon Disclosure Project (CDP). Read more
5 Mar 2024
Pharma Manufacturing News + Pharmaceutical Sustainability News
White Papers
New dosage forms come with new challenges:
A guide to overcoming analysis and quality control issues in R&D and manufacture. Read more
Sponsored Content
Trends in Solid Dosage Forms and their Challenges for R&D and Manufacture
CI Precision explore the trends in solid dosage forms and their challenges for R&D and manufacture. Read more
4 Mar 2024
09:25